Evidence map›Paper›PMID 32205222›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2020

Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis.

Jasmohan S Bajaj, Andres Duarte-Rojo, Jesse J Xie, Chathur Acharya, James B Wade, Carlos Robles, Leroy R Thacker, Christopher Flud, Andrew Fagan, Mauricio Garcia-Saenz-de-Sicilia and 5 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Acute and non-acute decompensation of liver cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Jasmohan S BajajVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia. Electronic address: jasmohan.bajaj@vcuhealth.org.
Andres Duarte-RojoUniversity of Arkansas School of Medical Sciences, Little Rock, Arkansas.
Jesse J XieUniversity of Arkansas School of Medical Sciences, Little Rock, Arkansas.
Chathur AcharyaVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.
James B WadeVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Carlos RoblesMayo Clinic, Phoenix, Arizona.
Leroy R ThackerVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Christopher FludUniversity of Arkansas School of Medical Sciences, Little Rock, Arkansas.
Andrew FaganVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Mauricio Garcia-Saenz-de-SiciliaUniversity of Arkansas School of Medical Sciences, Little Rock, Arkansas.
Melanie B WhiteVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Megan KellyMayo Clinic, Phoenix, Arizona.
Vy NguyenMayo Clinic, Phoenix, Arizona.
Edith A GavisVirginia Commonwealth University Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Hugo E VargasMayo Clinic, Phoenix, Arizona.
Hunter Holmes McGuire VA Medical Center · USMayo Clinic Hospital · US

Funding

Health IT generated PROs to Improve Outcomes in CirrhosisR01HS025412 · AHRQ · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2018 to 2022
$2.0M
Modulation of Gut-Brain Axis Using Fecal Microbiome Transplant Capsules in CirrhosisR21TR002024 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2017 to 2018
$414k
Fecal Microbiota Transplant in Veterans with CirrhosisI01CX001076 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI BAJAJ, JASMOHAN S · 2015 to 2024
–
AHRQ HHS R01 HS025412CSRD VA I01 CX001076NCATS NIH HHS R21 TR002024
6 · The paper itself

Abstract

BACKGROUND &

aimsPatients with cirrhosis are growing older. The overlap between minimal hepatic encephalopathy (MHE) and predementia mild cognitive impairment (MCI) could affect quality of life (QOL). We investigated the performance of elderly patients with cirrhosis on tests for MHE and MCI and their effects on QOL.

methodsWe recruited outpatients with cirrhosis (n = 109) and without cirrhosis (controls, n = 100), 65 years or older, at 4 centers (derivation cohort). All study participants were assessed for psychometric hepatic encephalopathy score (PHES), EncephalApp score, and QOL. MCI was tested in patients with cirrhosis using the repeatable battery for assessment of neuropsychological status and assigned to the following groups: unimpaired, MCI only, MHE only, and MCI+MHE. We created adjusted norms to detect MHE using PHES and EncephalApp scores from the controls. Findings were validated using data from a separate cohort of 77 patients with cirrhosis (mean age, 69.49 ± 4.36 y; 72% men) at the same study sites.

resultsControls were older but were more educated, performed better cognitively, and had better QOL. Among patients with cirrhosis, age, education, model for end-stage liver disease score, EncephalApp score, and QOL were similar, but PHES and repeatable battery for assessment of neuropsychological status differed among sites. In the derivation cohort, the presence of MHE, with or without MCI, was associated with poor QOL, which was lowest in the MCI+MHE group. When we adjusted for age, sex, and education, 49% of patients with cirrhosis had MHE based on the EncephalApp and 8% had MHE based on the PHES. A similar pattern (49% MHE based on EncephalApp and 6% MHE based on PHES) was found in a validation cohort.

conclusionsIn a multicenter study of patients with cirrhosis (>65 y) and controls, the presence of MHE, regardless of MCI, was associated with poor cognition and QOL. We created adjusted norms that defined the high sensitivity of EncephalApp for the detection of MHE in older individuals and validated it in a separate cohort.

Indexed as

Cognitive DysfunctionEnd Stage Liver DiseaseHepatic EncephalopathyAgedFemaleHumansLiver CirrhosisMalePsychometricsQuality of LifeSeverity of Illness IndexAgingDaily FunctionDementiaMemoryTransplant Selection

Identifiers

PMID32205222
PMCPMC7502426
OpenAlexW3012926238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.